Contribute Try STAT+ Today

President Trump’s temporary ban on immigration from seven predominantly Muslim countries could hamper bioscience research, according to Hakim Djaballah, a biotech consultant in New York.

Djaballah, who works in the fields of aging, infectious disease, and oncology, is on the board of the Pasteur Institute of Iran, and he’s concerned that mounting tensions between the US and countries affected by the 90-day ban — Iran, Iraq, Libya, Somalia, Sudan, Syria, and Yemen — might impede scientific progress. Here’s what he had to say, edited for clarity:

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Those who danced where thought to be quite insane by those who could not hear the music.

  • Here’s also why a lot of this is hyperbolic. Companies like Pfizer have shut down huge numbers of their domestic labs and used the savings to buy videoconferencing systems. So the lab protocol gets written in USA sent Pfizer Transylvania Laboratories, and the results are sent back to PFE. Everything is done electronically without the infrastructure of an American laboratory. No muss, no fuss, a weekly videoconference takes the place of live meetings.

  • For at least 30 years talented American chemists have been laid off in favor of H1b’s who come in at the bottom end of the salary range and keep America’s jobs in perpetuity. Maybe now things will be looking up for the American Pharma lab worker.

Comments are closed.